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OBJECTIVES The aim of this study was to perform an investigation of the effects of the longitudinal
straightening of coronary arteries by stents and the possible association with major adverse
cardiac events (MACE) (primary end point) and angiographic restenosis (secondary end
point).
BACKGROUND Stent deployment straightens a tortuous artery, and any consequent arterial longitudinal
stretch may contribute to MACE and stent restenosis severity.
METHODS Clinical, qualitative and quantitative angiographic data on 404 patients with single stent
implantation were subjected to multivariate nominal logistic regression analysis for the
prediction of MACE. The predictive accuracy, sensitivity and specificity values and cut-off
points of the continuous variables were determined via receiver operating characteristics
curves. The longitudinal straightening effect of stents was characterized through the changes
in vessel angle (defined by the tangents to the proximal and distal parts of the stenoses/stents).
RESULTS Follow-up angiography on 354 patients revealed 73 cases of stent restenosis ($50% diameter
stenosis). Coronary bypass surgery was performed in 4 patients and repeated percutaneous
transluminal coronary angioplasty in 56 patients; acute myocardial infarction (AMI) occurred
in 2 patients, and 4 patients died during the follow-up. The overall incidence of MACE
(death, AMI and revascularization) was 16.3% (66 patients). The best predictive accuracies
and sensitivities/specificities of factors indicative of MACE were found for the minimal
lumen diameter (MLD) at follow-up (predictive accuracy: 0.9305, sensitivity/specificity:
86.6%), the post-stent MLD (0.773, 77.2%), the percent diameter stenosis (%DS) at
follow-up (0.9432, 87.1%), the prestent vessel angulation (0.6797, 68.2%) and the poststent
changes in vessel angulation (0.6279, 62.2%). Multivariate nominal logistic regression analysis
demonstrated that a poststent MLD #2.63 mm (p 5 0.0017, odds ratio [OR] 5 17.961,
95% confidence interval [CI] 5 17.45–20.428), an MLD at follow-up #1.7 mm (p 5
0.0059, OR 5 11.880, 95% CI 5 11.490–14.093), a %DS at follow-up $42.2% (p 5 0.0000,
OR 5 49.553, 95% CI 5 48.024–53.507), a prestent vessel angulation $33.5° (p 5 0.0477,
OR 5 5.404, 95% CI 5 5.382–7.142) and poststent changes in vessel angulation $9.1° (p 5
0.0026, OR 5 19.161, 95% CI 5 18.562–21.750) were significant predictors for MACE.
Multiple linear regression revealed that the poststent MLD (multivariate p 5 0.0001), the
MLD at follow-up (p 5 0.0000), the prestent vessel angulation (p 5 0.0431) and the changes
in vessel angulation after stent implantation (p 5 0.0316) were significant independent
variables predicting angiographic stent restenosis severity.
CONCLUSIONS The longitudinal straightening effect of coronary artery stents contributes significantly to the
occurrence of MACE and angiographic restenosis, and this finding may have an impact on
future stent design. (J Am Coll Cardiol 2000;35:1580–9) © 2000 by the American College
of Cardiology
The two most important features of a coronary stent are
basic to its use: the radial force with which it supports the
vessel and its longitudinal flexibility, one of the major
determinants of its trackability into the target lesion before
deployment (1). Accordingly, the ideal coronary stent would
be very flexible and should have high radial strength to avoid
collapse due to the pressure exerted on it by a diseased artery
wall, but it should adapt easily to changes in diameter and
tortuosity due to coronary vasomotion and heartbeats.
These opposing demands on stents have led to a multiplicity
of designs, each of them being a compromise.
Numerous studies have examined the roles of various
clinical, angiographic and procedural factors influencing the
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patient’s outcome after stent deployment (2–4). Several
predictors of stent restenosis have been identified in recent
studies, including patient-related factors such as diabetes
mellitus (5,6), restenotic lesion (7), lesion length (8), smaller
vessel size (9–11) and procedural variables such as the final
minimal lumen diameter (MLD) (10,12), stenting of the
total occlusion (13), multiple stent implantation (10,14) and
bail-out conditions (11).
The starting point of this study was the angiographic
observation that, apart from the radial arterial wall stretch,
stent implantation straightens the coronary artery and par-
ticularly a tortuous vessel. We defined two geometric effects
of stents on the vessel wall (Fig. 1): (a) the radial stretch,
which increases the lumen diameter but does not change the
angles between the lumen axis and the tangents, and (b)
longitudinal straightening, which decreases the angles be-
tween the lumen axis and the tangents, i.e., it decreases the
curvature of the vessel but does not necessarily affect the
lumen diameter. In contrast with the beneficial effect of the
radial stretching effect of a stent (e.g., inhibition of con-
strictive remodeling), the longitudinal straightening effect of
a stent on an artery may theoretically provoke neointimal
hyperplasia and contribute to restenosis.
The aim of our study, therefore, was to investigate the
longitudinal straightening effect of stent implantation on
the coronary artery, as a possible additional risk factor for
major adverse cardiac events (MACE) and angiographic
restenosis, and the correlation between MACE, restenosis
and the changes in vessel curves due to stent implantation in
concordance with the other predictors for MACE and
restenosis in a group of consecutive unselected patients with
stent implantation.
METHOD
Study patients. Between June 1997 and September 1998,
coronary artery stents were implanted in 520 of 922 (56.4%)
consecutive coronary angioplasties performed in our cathe-
terization laboratory. Additionally, 151 patients participat-
ing in two prospective multicenter studies involving stent
implantation were also included in the present retrospective
data analysis, because there were no differences in the
standard circumstances of stent placement and patient
management, no differences in patient outcome were dem-
onstrated (15,16), and the quantitative angiographic data
were all analyzed in our angiographic core laboratory. Thus,
for the purposes of this study, all 671 patients were pooled
and regarded as one group. The indications for stenting
were elective suboptimal results ($20% residual diameter
stenosis) after percutaneous transluminal coronary angio-
plasty (PTCA), either with or without dissection, and
bail-out conditions. Of the total of 671 consecutive candi-
dates, the following criteria led to the exclusion of 267
patients: 104 patients with multiple stent implantation, 61
patients with stent deployment on a coronary bypass graft,
23 patients with stent delivery failure, 15 patients in whom
measurements of quantitative coronary angiographic data
were impossible and 64 patients with missing clinical data
during the planned six-month follow-up period. The data
on the 404 patients with single stent implantation (404
lesions in 404 patients) were then entered for the further
Abbreviations and Acronyms
CI 5 confidence interval
%DS 5 percent diameter stenosis
LAD 5 left anterior descending coronary artery
MACE 5 major adverse cardiac events
MLD 5 minimal lumen diameter
OR 5 odds ratio
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QCA 5 quantitative coronary angiography
RD 5 reference diameter
ROC 5 receiver operating characteristic
Figure 1. Schematic outline of the radial stretching (left) and longitudinal straightening (right) effect of the stent.
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retrospective analysis. Follow-up angiography at a mean of
10.1 6 5.6 months was carried out in 354 patients (87.6%).
The clinical variables included the presence of coronary risk
factors such as hypertension (medication-dependent only),
diabetes mellitus (medication-dependent only), hypercho-
lesterolemia (medication-dependent or serum cholesterol
$240 mg/dl), smoking, a familial history of coronary artery
disease, a history of previous myocardial infarction, the
angina pattern, age, gender, native or restenotic lesion,
lesion localization (left anterior descending coronary artery
[LAD] or non-LAD and proximal lesions), type C lesion,
stent balloon diameter, maximal balloon inflation pressure
and the occurrence of MACE; the angiographic data,
including the MLD, the reference segment diameter (RD),
percent diameter stenosis (%DS), the vessel angulation
before and after stent implantation, the changes in vessel
angulation after stent implantation and the acute lumen
gain (difference between post- and preangioplastic MLD)
were recorded for all patients. Follow-up coronary angio-
graphic data on the 354 patients undergoing control angiog-
raphy were also analyzed.
Stent implantation procedures and poststenting treat-
ment. Lesion-specific stenting was applied in all cases, with
the majority of the stents being AVE Micro (10.5%), AVE
GFX (12.1%), Palmaz-Schatz (17.6%), Wiktor (38.1%) or
Paragon (19.1%). Smaller numbers of Multilink, ACT-1,
NIR and Bestent stents were implanted in 3.6% of the cases.
Coronary angiography and stent placement were performed
in a routine manner. Patients received intracoronary nitro-
glycerine before the initial, final and follow-up angiograms
in order to achieve maximal vasodilation. All patients were
given aspirin (100 mg once daily) and ticlodipin (250 mg
twice daily) after stenting. All procedures were carried out in
accordance with the institutional guidelines.
Angiographic analysis. Angiograms were obtained in mul-
tiple projections at baseline, immediately after stent place-
ment and at the planned six-month follow-up. Quantitative
angiography (QCA) was performed with the use of a
computer-assisted coronary angiographic measurement sys-
tem (CMS Version 2.3D, MEDIS, Leiden, the Nether-
lands) which has undergone extensive validation studies and
has been described in detail elsewhere (17). The diameters
of the proximal and distal reference segments were averaged
to yield MLD, RD and %DS. Each QCA variable was
taken as the mean value from multiple matched views.
Vessel angulations were determined as the angles defined
by the tangents to the proximal and distal parts of the
stenoses/stents at the end-diastolic angiographic frames
(Fig. 2). Vessel angulations before and after stent implan-
tation and at follow-up were measured in each available
angiographic view, and the greatest angulation of the lesion
was entered in the further statistical procedures. Vessel
Figure 2. Different effects of stent implantation on vessel angulation. Upper right and left: coronary artery before and after stent
implantation; lower right and left: vessel curve measurements at the level of the stenosis/stent.
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angulations were measured by two independent observers,
and the mean values of two measurements were taken for
further consideration.
Study end points. Major adverse cardiac events (primary
end point of the study) were defined as death, nonfatal acute
myocardial infarction or revascularization by PTCA or
coronary artery bypass grafting.
Restenosis severity (secondary end point of the study) was
determined as the %DS measured at the narrowest segment
within the stent at follow-up angiography.
Changes in vessel angulation after stent implantation and
at follow-up were calculated as the differences between pre-
and poststent vessel angulations and between poststent and
follow-up vessel angulations, respectively.
Data analysis and statistical methods. MACE as primary
end point. For the statistical analysis, all continuous vari-
ables (age, stent diameter, maximal stent-balloon inflation
pressure, balloon/artery ratio, stenosis length, pre- and
poststent and follow-up MLDs, RDs and %DSs) were
transformed to binary data, with 1 for the presence and 0 for
the absence of risk factors for MACE. The cut-off point of
this division was established on the basis of receiver oper-
ating characteristic (ROC) curves, which presented not only
the best cut-off point of each continuous variable for
predicting MACE, but also the predictive accuracy and the
sensitivity and specificity values for each variable for the
prediction of MACE. In the cases where there was an
inverse association between the parameter and the occur-
rence of MACE (e.g., MLD, a smaller MLD with more
MACE), the reciprocal values of these parameters (MLD
and RD) were used, while in the other cases (i.e., the %DS,
a higher %DS with more MACE), the original values were
entered in the ROC analyses. The predictive accuracy of
each parameter was calculated as the area under the ROC
curve. The best cut-off points of the parameters were
determined on the basis of the same sensitivity and speci-
ficity values. We used the points of intersection of the
sensitivity and specificity curves as cut-off points (MACE
yes or MACE no) because the availability of a better
sensitivity through increase of the cut-off point would result
in a worse specificity.
Uni- and multivariate stepwise logistic regression analysis
was then carried out to identify independent correlates for
MACE. First, all potential risk factors were tested in a
univariate regression analysis. The interactions between
multiple collinear variables were tested by using the Pearson
correlation. In order to avoid collinearity and to correct the
multiple comparison, the acute lumen gain (difference
between pre- and poststent MLD), late lumen loss (differ-
ence between poststent MLD and MLD at follow-up),
vessel angulation after stent implantation and vessel angu-
lation at follow-up exhibiting a strong correlation (p ,
0.01) with at least one other parameter were excluded from
the further analysis. In the second step, all remaining
variables with alpha #0.10 were entered into the multivar-
iate logistic regression analysis. The relative risks of the
significant predictors for the occurrence of MACE were
expressed by using the odds ratio (OR) with 95% confidence
intervals (CI).
Angiographic restenosis severity as secondary end point. To
study the relation between angiographic restenosis severity
(continuous outcome variable) and multiple categoric and
continuous determinants, multiple linear regression was
performed. All possible risk factors were correlated with the
follow-up angiographic %DS, and variables presenting al-
pha ,0.1 were included in the multiple regression analysis.
Data are expressed as means 6 SD for continuous
variables and percentages for categoric variables. The Stu-
dent t test was used for data comparison within groups
(vessel angulation prestent, poststent and at follow-up).
Statistical significance was considered present if p , 0.05.
The statistical analyses were performed with the standard
SAS package and CLABROC and LABROC computer
software designed by Metz (18,19).
Assessment of reproducibility of the vessel angulation mea-
surements. Vessel angulation of 54 different stented vessels
were measured by two independent observers in separate
sessions, and the interobserver variability was calculated by
using regression analysis. For determination of the intraob-
server variability, 68 vessel angulations of stented vessels
were measured three times by one observer. The intraob-
server variability and the reproducibility of vessel angulation
measurements were determined by using one-way analysis
of variance with repeated measurements. The methodolog-
ical error was calculated for the standard error of the analysis
of variance. The different analyses included the error in-
volved in the repeatedly selected arterial segment and the
error involved in the repeated measurements on the vessel
angulation.
The coefficient of correlation of the interobserver vari-
ability was r 5 0.9352 (p , 0.001). The coefficient of
variation of the repeated measurements of the vessel angu-
lation was 8.6%. The methodological error in the vessel
angulation measurements was 2.1°. Thus, a two-fold meth-
odological error (4.2°) can be regarded as a statistically
significant difference between two vessel angulation mea-
surements.
RESULTS
MACE as primary end point. Table 1 presents the base-
line clinical and angiographic data. During the 10.2 6 5.9
month clinical follow-up period, the overall incidence of
MACE was 16.3% (n 5 66). Acute myocardial infarction
due to stent restenosis/occlusion occurred in 2 patients, and
death in 4 patients; 73 lesions displayed target lesion
restenosis at follow-up angiography. Coronary artery bypass
grafting was performed in 4 patients and repeat PTCA in 56
patients.
Table 2 summarizes the cut-off points, predictive accu-
racies and sensitivity/specificity values of each continuous
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variable for predicting MACE. The best predictive accuracy
was found for the %DS at follow-up (cut-off point: 42.2%),
the MLD at follow-up (cut-off point: 1.7 mm), the post-
stent MLD (cut-off point: 2.63 mm), the prestent vessel
angulation (cut-off point: 33.5°) (Fig. 3) and the changes in
vessel angulation after stent implantation (cut-off point:
9.1°).
The association of all nominal factors with MACE is
detailed in Tables 3 and 4, which contain the results of uni-
and multivariate nominal logistic regression analysis. Mul-
tivariate nominal logistic regression analyses demonstrated
that a poststent MLD # 2.63 mm, an MLD at follow-up
#1.70 mm, a %DS at follow-up $42.2%, a prestent vessel
angulation $33.5° and changes in vessel angulation after
stent implantation $9.1° were independent predictors for
MACE and represented an increased risk of MACE, with
the OR ranging from 5.404 to 49.553 (Table 5).
The occurrence of MACE was associated with more
pronounced straightening in the stented artery (36.5 6 20°
before stent implantation, 23.4 6 19.3° after stent implan-
tation and 20.0 6 15.3° at follow-up in patients with
MACE, 32.8 6 22.8° before stent implantation, 25.7 6
18.9° after stent implantation and 25.3 6 19.5° at follow-up
in patients without MACE; Fig. 4).
Angiographic restenosis severity as secondary end point.
Multiple regression analyses revealed significant correlations
between the stenosis severity at follow-up and the poststent
MLD (p 5 0.0001), the MLD at follow-up (p 5 0.000),
the prestent vessel angulation (p 5 0.0431) and the changes
in vessel angulation after stent implantation (p 5 0.0316).
DISCUSSION
The major finding of this study was that, besides the known
predictors of MACE and restenosis severity after stent
implantation (final angiographic results in terms of MLD
after stent implantation, and at follow-up, %DS at follow-
up), a prestent vessel angulation of more than 33.5° and
changes in vessel angulation after stent implantation of
more than 9.1° are additional independent predictors for
MACE and restenosis.
Predictors for MACE. As has been described for native
coronary lesions by Lehmann et al. (20) and for stented
lesions by Scho¨mig et al. (21), the frequency-distribution
curves of angiographic measures of restenosis display a
bimodal pattern, suggesting the existence of two distinct
populations with normal Gaussian distribution with differ-
ent propensities to restenosis. For this reason, in our study
ROC analyses were used to determine the predictive accu-
racy with sensitivity and specificity values for all continuous
clinical and angiographic variables with the possibility of
predicting MACE. As expected from the characters of the
parameters, MLD and %DS at follow-up indicated the best
predictive accuracy, sensitivity and specificity values for the
occurrence of MACE. Prestent vessel angulation and
changes in vessel angulation after stent implantation showed
a similarly acceptable predictive accuracy but slightly worse
sensitivity and specificity values. On the basis of the ROC
curves, the other parameters were not suitable for predicting
MACE. As could be anticipated from the ROC analyses,
the poststent and follow-up MLD, the %DS at follow-up,
the prestent vessel angulation and the changes in vessel
angulation after stent implantation proved to be significant
predictors for the occurrence of MACE, and these param-
eters present a high risk of an adverse outcome after
coronary stent placement.
Relation to other studies. Since there are numerous liter-
ature data on the limitations of the angiographic assessment
of the physiologic significance of lesion severity, we chose
Table 1. Clinical and Angiographic Baseline Characteristics for
Study Patients (n 5 404)
Age 61.1 6 10.7
Male 319 (79.0%)
Unstable angina 156 (38.6%)
Previous myocardial infarction 144 (35.6%)
Restenosis 68 (16.8%)
Type C lesion 126 (31.2%)
LAD 166 (41.1%)
Risk Factors




Familial history 58 (14.4%)
Indication for Stenting
Elective 194 (48.0%)
After PTCA 193 (47.8%)
Bail out 17 (4.2%)
Stent Data
Stent diameter (mm) 3.37 6 0.37
Maximal pressure (atm) 12.26 6 2.93
Balloon/artery ratio 1.16 6 0.24
Quantitative Coronary Angiographic Data
MLD prestent (mm) 1.12 6 0.49
MLD poststent (mm) 2.75 6 0.51
MLD follow-up (mm) 2.08 6 0.83
Reference diameter prestent (mm) 3.01 6 0.61
Reference diameter poststent (mm) 3.35 6 0.53
Reference diameter follow-up (mm) 3.14 6 0.66
%DS prestent (%) 62.1 6 15.5
%DS poststent (%) 17.9 6 9.6
%DS follow-up (%) 34.1 6 21.0
Stenosis length prestent (mm) 8.88 6 3.82
Acute lumen gain 1.64 6 0.61
Late lumen loss 0.73 6 0.79
Vessel Angulation
Vessel angulation prestent (°) 35.1 6 22.3
Vessel angulation poststent (°) 25.3 6 19.3
Vessel angulation follow-up (°) 24.3 6 19.6
Changes in vessel angulation pre/post stent (°) 10.8 6 13.9
Changes in vessel angulation at follow-up (°) 6.5 6 13.2
MLD 5 minimal lumen diameter; %DS 5 percent diameter stenosis.
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MACE (clinical restenosis) as primary end point, from a
clinical point of view (22). The clinical outcome is generally
of greater interest to patients and the society than the
angiographic assessment, and, thus, the clinical recurrence
may be a better factor in the patient management than
angiographic restenosis (22).
Our results are mostly concordant with the findings of
other studies in terms of predictors of restenosis, even if we
chose MACE as primary end point (23–25). The postin-
terventional and follow-up angiographic results have been
shown to be correlated with the likelihood of restenosis
(10,24,26). In contrast with other studies, where age,











Age (yr) 61.00 0.4880 48.7 $61
Balloon/artery ratio 1.14 0.5170 51.3 $1.14
Stent diameter (mm) 3.40 0.4828 48.7 $3.4
Max. stent inflation pressure (atm) 12.20 0.4532 46.6 $12.2
MLD prestent (mm) 1.13 0.5246 52.5 #1.13
MLD poststent (mm) 2.63 0.7730 77.2 #2.63
MLD follow-up (mm) 1.70 0.9305 86.6 #1.7
Ref. D. prestent (mm) 2.97 0.4759 55.2 #2.97
Ref. D. poststent (mm) 3.30 0.4238 52.2 #3.3
Ref. D. follow-up (mm) 3.00 0.5790 55.6 #3.3
%DS prestent (%) 61.30 0.4991 50.0 $61.3
%DS poststent (%) 18.50 0.5937 56.5 $18.5
%DS follow-up (%) 42.20 0.9432 87.1 $42.2
Stenosis length prestent (mm) 7.84 0.5366 52.5 $7.84
Acute lumen gain (mm) 1.523 0.6280 60.9 #1.523
Late lumen loss (mm) 0.99 0.7680 69.4 $0.99
Vessel angulation prestent (°) 33.50 0.6797 68.2 $33.5
Vessel angulation poststent (°) 19.40 0.4380 45.3 $19.4
Vessel angulation follow-up (°) 18.60 0.3976 42.4 $18.6
Changes in vessel angulation
poststent (°)
9.10 0.6279 62.2 $9.1
Changes in vessel angulation at
follow-up (°)
4.90 0.5224 52.2 $4.9
MLD 5 minimal lumen diameter; %DS 5 percent diameter stenosis; Ref. D. 5 reference diameter.
Figure 3. Predictive accuracy (ROC curve) of the prestent vessel angulation for predicting MACE (left). The closer the ROC curve is to
the upper left-hand corner of the graph, the more accurate it is, because the true-positive rate is 1 and the false-positive rate is zero.
Additional delineation of sensitivity and specificity curves relating to each prestent vessel angulation value and the determination of a
cut-off point for the same sensitivity and specificity for predicting MACE (right). MACE 5 major adverse cardiac events; ROC 5
receiver operating curve.
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gender, small vessel diameter, diabetes mellitus, type C and
LAD lesions, restenotic lesions and %DS after stent im-
plantation were significant predictors for restenosis, none of
these clinical or angiographic variables tested in our study
were associated with MACE (3,11,26–28). The lack of
concordance of the findings between our own and the above
mentioned studies may result from the different patient-
selection criteria: we chose only patients with single stent
implantation who had angiographic follow-up or well-
documented clinical follow-up data. Finally, different cut-
off points for continuous variables (to transform the contin-
uous variables to binary data) may also cause different end
results; mostly the median of the variables or the intersec-
tion point between the two theoretical normal distribution
components (restenosis yes or no) was used in the other
studies (29).
Predictors for angiographic restenosis. From a statistical
perspective, significant power may be lost in the assay by
dichotomizing all continuous parameters according to arbi-
trary cutoff points, even if those cutoff points were selected
to maximize sensitivity and specificity. In order to surmount
this statistical conflict, we analyzed all continuous data in





(n 5 338) p Value p Value
Clinical Data Risk Factor Present Risk Factor Present Univariate Multivariate
Age $ 61 yr 34 (51.5%) 170 (50.3%) 0.8809
Male 57 (86.4%) 262 (77.5%) 0.0658 0.1871
Diabetes mellitus 11 (16.7%) 58 (17.2%) 0.8911
Hypertension 30 (45.5%) 167 (49.4%) 0.9198
Hypercholesterolemia 33 (50.0%) 177 (52.4%) 0.8505
Smoking 23 (34.8%) 120 (35.5%) 0.7742
Family history 12 (18.2%) 46 (13.6%) 0.7924
Previous infarct 19 (28.8%) 125 (37.0%) 0.1632
Unstable angina 23 (34.8%) 133 (39.3%) 0.4579
Restenotic lesion 13 (19.7%) 55 (16.3%) 0.5037
LAD lesion 30 (45.5%) 136 (40.2%) 0.4909
Type C lesion 23 (34.8%) 103 (30.5%) 0.5520
Indication for Stent
Implantation
Elective 32 (48.5%) 162 (47.9%) 0.1892
After PTCA 30 (45.4%) 163 (48.2%) 0.2869
Bail out 4 (6.1%) 13 (3.8%) 0.7166
LAD 5 left anterior descending artery; MACE 5 major adverse cardiac events.
Table 4. Results of Uni- and Multivariate Analysis for Predicting MACE
Risk Factors MACE yes (n 5 66) MACE no (n 5 338) p Value p Value
Angiographic Data Risk Factor Present Risk Factor Present Univariate Multivariate
Maximimal stent balloon pressure $ 12.2 mm Hg 21 (31.8%) 137 (40.5%) 0.9109
Stent diameter $ 3.4 mm 32 (48.5%) 175 (51.8%) 0.1807
Balloon/artery ratio $ 1.14 27 (40.9%) 138 (40.8%) 0.8452
MLD prestent # 1.13 mm 37 (56.1%) 187 (55.3%) 0.9320
MLD poststent # 2.63 mm 34 (51.5%) 113 (33.4%) 0.0000 0.0017
MLD follow-up # 1.7 mm 37 (56.1%) 20 (5.9%) 0.0000 0.0059
RD prestent # 2.97 mm 32 (48.5%) 142 (42.0%) 0.4940
RD poststent # 3.3 mm 35 (53.0%) 146 (43.2%) 0.2408
RD follow-up # 3.0 mm 22 (33.3%) 80 (23.7%) 0.1496
%DS prestent $ 61.3% 33 (50.0%) 148 (43.8%) 0.5283
%DS poststent $ 18.5% 33 (50.0%) 130 (38.4%) 0.0129 0.0764
%DS follow-up $ 42.2% 40 (60.6%) 12 (3.6%) 0.0000 0.0000
Stenosis length prestent $ 7.84 mm 17 (25.8%) 65 (19.2%) 0.1205
Vessel angulation prestent $ 33.5° 34 (51.1%) 129 (38.2%) 0.0009 0.0477
Changes in vessel angulation poststent $ 9.1° 36 (54.5%) 136 (40.2%) 0.0209 0.0026
Changes in vessel angulation at follow-up $ 4.9° 39 (59.1%) 159 (47.4%) 0.0046 0.7356
MACE 5 major adverse cardiac events; MLD 5 minimal lumen diameter; %DS 5 percent diameter stenosis; RD 5 reference diameter.
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their raw form via uni- and multiple regression analyses.
However, there were no differences between the outcome
results with regard to the two different (clinical and angio-
graphic) end points, as the same parameters correlated
significantly with the angiographic restenosis severity and
MACE. These results were expected on the basis of the
occurrence of a few deaths and nonfatal AMI cases.
Alteration in vessel geometry in relation to restenosis
and MACE. Although it has been shown that, through
mild overstretch of the stented segment, the radial stretch of
the stented artery reduces clinical events, the longitudinal
straightening effect of stents seems to be injurious to the
arterial patency. Although the average vessel angulation was
decreased significantly immediately after stent implantation
in both patients with and patients without MACE, it was
further decreased at follow-up in patients with MACE,
while in patients without MACE, there was no further
decrease in the curve of the stented arterial segment. These
results confirm our hypothesis that the change in arterial
path due to stent implantation is a trigger for the progres-
sion of coronary vascular atherosclerosis and the occurrence
of MACE. Although the exact mechanism by which this
occurs is unknown, several factors related to arterial longi-
tudinal straightening may be responsible for the develop-
ment of restenosis and MACE. The alteration in vessel
geometry after stent implantation provokes mechanical
longitudinal stretching of the smooth muscle cells and
intimal cells, leading to a series of cellular and subcellular
biochemical pathways and cascades, such as the secretion of
different growth factors (e.g., platelet-derived growth fac-
tor), cytokines and mitogens, which has been shown to
stimulate the proliferative response to vascular injury (30–
33). Moreover, in addition to stretch of the wall on one side
of the stent, there is folding and redundancy on the opposite
wall. It may be that both the folded and stretched sides of
the stent induce biochemical changes leading to stent
restenosis.
It should be noted that a wide range of stents, including
relatively rigid Palmaz-Schatz and flexible coil stents (Wik-
tor), were analyzed without separation in this study. We
have started to examine the effects of vessel angulation
(alone and together with other parameters) of different
stents on the occurrence of MACE and angiographic resten-
osis, and partial results have already been published (34).
Study limitations. There is no objective tool for the
determination of vessel angulation, and an attempt was,
therefore, made to avoid subjectivity in the measurement of
vessel curves before and after stent implantation and at
follow-up through measurements made by two independent
angiographic experts and through determination of inter-
and intraobserver variabilities. The appearance of the vessel
angulation depends on the angiographic view, and it may
happen that the standard angiographic record is not able to
reveal the maximal vessel angulation. However, despite all
the limitations of the curve measurements, determination of
the vessel angulation proved to be a suitable parameter for
the prediction of MACE with acceptable predictive accu-
racy, sensitivity and specificity and inter- and intraobserver
variability. Many of the stents used in this study have
potentially widened gaps between adjacent coils when
placed in highly angulated lesions, which might result in
significantly smaller MLDs than thought. This would be
evident only on intravascular ultrasonography, perhaps be-
ing totally undetectable by QCA. A further limitation of the
study is the selection of the patients. Although the selected
population appears to be representative of most angioplasty
candidates with single stent implantation, the findings
obtained in patients with multiple stent implantation may
differ; however, the implantation of multiple stenting, pos-
sibly involving different stent types, affects the vessel angu-
lation in a more complex way. We excluded patients on
whom clinical follow-up data were not available, but this
exclusion criterion concerned only 9.5% of all study candi-
dates.
Conclusions. In our study including patients with single
stent implantation, a poststent MLD # 2.63 mm, an MLD
Table 5. Odds Ratio and 95% Confidence Intervals of








MLD poststent # 2.63 mm 17.961 17.450–20.428
MLD follow-up # 1.7 mm 11.880 11.490–14.093
%DS follow-up $ 42.2% 49.553 48.024–53.507
Vessel angulation prestent $ 33.5° 5.404 5.382–7.142
Changes in vessel angulation
poststent $ 9.1°
19.161 18.562–21.750
Changes in vessel angulation
at follow-up $ 4.9°
0.741 0.677–1.464
MLD 5 minimal lumen diameter; %DS 5 percent diameter stenosis.
Figure 4. Vessel angulation prestent, poststent and at follow-up in
patients with or without MACE. Gray bar 5 prestent; black
bar 5 poststent; striped bar 5 follow-up.
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at follow-up #1.7 mm, a %DS at follow-up $42.2%, a
prestent vessel angulation $33.5° and changes in vessel
angulation after stent implantation $9.1° indicated a sig-
nificant risk of the occurrence of MACE (primary end
point). The ROC analyses revealed that the poststent
MLD, the MLD at follow-up and the %DS at follow-up
furnished the best predictive accuracy, sensitivity and spec-
ificity values for the prediction of MACE. Although the
average vessel angulation after stent implantation had de-
creased significantly in both patients with and without
MACE, the further decrease in vessel curve at follow-up
was significantly associated with MACE. Multiple regression
analyses demonstrated that the poststent and follow-up MLD,
the prestent vessel angulation and the changes in vessel
angulation after stent implantation were significant indepen-
dent variables for predicting target lesion restenosis (secondary
end point) at follow-up. Our results indicate that the prestent
vessel angulation and the changes in vessel angulation after
stent implantation should be regarded as predictive parameters
in the clinical practice of coronary stenting; moreover, these
findings may have an impact on future stent design.
APPENDIX
Austrian Wiktor Stent Study Group: Division of Cardiology,
Second Department of Internal Medicine, University Med-
ical School of Vienna, Vienna, Austria (Dietmar Glogar,
MD, FESC), University Clinic of Second Department of
Internal Medicine, Landeskrankenanstalten Salzburg,
Salzburg (Guenter Heyer, MD), Department of Internal
Medicine, Karl Franzens University, Graz (Werner Klein,
MD, Olef Luha, MD), Department of Internal Medicine,
University Hospital of Innsbruck, Innsbruck (Volker
Muehlberger, MD), Department of Cardiology, Medical
Hospital Wels, Wels (Edwin Maurer, MD, Othmar Pach-
inger, MD), Second Medical Department, Landeskranken-
haus Klagenfurt, Klagenfurt (Josef Sykora, MD), Fifth
Department of Internal Medicine, Kaiser-Franz-Josef-
Hospital, Vienna, Austria (Heinrich Weber, MD).
European Paragon Stent Investigators: Division of Cardi-
ology, Second Department of Internal Medicine, University
Medical School of Vienna, Vienna, Austria (Dietmar
Glogar, MD, FESC), King’s College Hospital, London,
United Kingdom (Martyn R. Thomas), Second Depart-
ment of Internal Medicine, Landeskrankenanstalten
Salzburg, Salzburg (Guenter Heyer, MD), University Clin-
ics of Zurich, Switzerland (Wolfgang Amann), CHUV,
Lausanne, Switzerland (Eric Eeckhout), Second Medical
Department, Landeskrankenhaus Klagenfurt, Klagenfurt
(Josef Sykora, MD).
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